Wu, J. et al. 2022. Trastuzumab therapies in human epidermal growth factor receptor 2 cancer. Highlights in Science, Engineering and Technology. 8, (Aug. 2022), 32–40. DOI:https://doi.org/10.54097/hset.v8i.1107.